Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

NSCLC · Locally Advanced

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Montefiore Einstein Comprehensive Cancer Center (MECCC), The Bronx, New York, United States
Contact: Study coordinator (Nitin Ohri, MD, MS) · nitin.ohri@einsteinmed.edu · 718-405-8550

Study leads

Nitin Ohri, MD, MS
Principal Investigator
Albert Einstein College of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Invasive Ductal Breast Carcinoma · Invasive Ductal Breast Carcinoma Stage IV · Lobular Breast Carcinoma

Abroad (travel likely)Recruiting

Basking Ridge, United States · Middletown, United States

ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs

NSCLC (Advanced Non-small Cell Lung Cancer) · EGFR Mutation Positive Advanced Non Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE2

Rochester, United States · Toronto, Canada

Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC

EGFR Mutation-positive NSCLC

Abroad (travel likely)RecruitingPHASE1

Beijing, China · Shandong, China